Skip to main content
Equibles
TMO logo

TMO · Thermo Fisher Scientific Inc. · Analyst Estimates

Track TMO — free

Use TMO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TMO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$693.02 +8.13 (+1.19%) At close · Oct 27 Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$256.84B
Shares
369.75M
Volume · Oct 27 1.83M Avg daily vol (3M) 2.13M

Analyst Estimates

Compare analyst forecasts for Thermo Fisher Scientific Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-27 21:22 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
25.03
25.26
25.40
27
25.15
25.13
25.12
25.10
0
0
4
4
Revenue
USD
Publication date not stated
47.73B
47.99B
48.22B
25
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
27.02
27.74
29.07
27
27.58
27.54
27.51
27.48
1
1
4
5
Revenue
USD
Publication date not stated
49.94B
50.51B
51.48B
25
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
7.00
7.14
7.34
21
7.28
7.26
7.28
7.28
0
1
2
1
Revenue
USD
Publication date not stated
12.72B
12.86B
13.03B
20
 — — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
5.64
6.05
6.53
13
6.02
6.01
6.00
5.99
0
0
1
1
Revenue
USD
Publication date not stated
11.60B
11.74B
11.98B
11
 — — — — — — — —
Key facts CIK 97745 CUSIP 883556102 13F (30d) 929 filings 902 filers Visit website Investor relations